FDA warns 2 companies to stop pushing CBD for opioid addiction
Industrial Hemp NewsMarijuana Laws, Regulations, & Politics April 27, 2020 MJ Shareholders 0
The U.S. Food and Drug Administration warned two companies to stop illegally marketing CBD products with claims that it can treat opioid addiction and other medical conditions.
The warning letters were sent Thursday to:
- BIOTA Biosciences, LLC, of Washington state
- Homero Corp., doing business as Nature’s CBD Oil Distribution of New Hampshire
“CBD has not been shown to treat opioid addiction. Opioid addiction is a real problem in our country, and those who are addicted need to seek out proper treatment from a health care provider,” FDA Principal Deputy Commissioner Amy Abernethy said a statement about the warnings.
The FDA accuses both companies of marketing and distributing CBD products for serious diseases and as an alternative to opioids.
The letters give the companies 15 days to demonstrate how they’ll correct the violations.
To read more about marketing CBD without running afoul of the FDA, click here.
Subscribe to our Newsletter
.LV_validation_message{ font-weight:bold; margin: 0 0 0 5px; } .LV_valid{ color:#00CC00; display:none; } .LV_invalid{ color:#CC0000; font-size:10px; } .LV_valid_field, input.LV_valid_field:hover, input.LV_valid_field:active, textarea.LV_valid_field:hover, textarea.LV_valid_field:active { outline: 1px solid #00CC00; } .LV_invalid_field, input.LV_invalid_field:hover, input.LV_invalid_field:active, textarea.LV_invalid_field:hover, textarea.LV_invalid_field:active { outline: 1px solid #CC0000; }
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.